A Pilot Trial of Adriamycin, Pembrolizumab, Vinblastine and Dacarbazine (Apvd) for Patients With Untreated Classical Hodgkin Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.21_2632

Related search